Liver

Transform

Transform is an investigational study in patients with a 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness.

Primary disease category:

Secondary disease category(ies):

Autoimmune Disorders

Zydus PBC

A randomized, double-blind, placebo-controlled phase 2b/3 study to evaluate the safety and efficacy of Saroglitazar Magnesium in subjects with Primary Biliary Cholangitis (PBC).

Primary disease category:

Secondary disease category(ies):

Zydus Nash

Prospective, Multi-Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium

Primary disease category:

Secondary disease category(ies):